Genomic and functional determinants of host spectrum in Group B Streptococcus

PLoS Pathog. 2024 Aug 12;20(8):e1012400. doi: 10.1371/journal.ppat.1012400. eCollection 2024 Aug.

Abstract

Group B Streptococcus (GBS) is a major human and animal pathogen that threatens public health and food security. Spill-over and spill-back between host species is possible due to adaptation and amplification of GBS in new niches but the evolutionary and functional mechanisms underpinning those phenomena are poorly known. Based on analysis of 1,254 curated genomes from all major GBS host species and six continents, we found that the global GBS population comprises host-generalist, host-adapted and host-restricted sublineages, which are found across host groups, preferentially within one host group, or exclusively within one host group, respectively, and show distinct levels of recombination. Strikingly, the association of GBS genomes with the three major host groups (humans, cattle, fish) is driven by a single accessory gene cluster per host, regardless of sublineage or the breadth of host spectrum. Moreover, those gene clusters are shared with other streptococcal species occupying the same niche and are functionally relevant for host tropism. Our findings demonstrate (1) the heterogeneity of genome plasticity within a bacterial species of public health importance, enabling the identification of high-risk clones; (2) the contribution of inter-species gene transmission to the evolution of GBS; and (3) the importance of considering the role of animal hosts, and the accessory gene pool associated with their microbiota, in the evolution of multi-host bacterial pathogens. Collectively, these phenomena may explain the adaptation and clonal expansion of GBS in animal reservoirs and the risk of spill-over and spill-back between animals and humans.

MeSH terms

  • Animals
  • Cattle
  • Fishes / microbiology
  • Genome, Bacterial*
  • Genomics
  • Host Specificity / genetics
  • Humans
  • Phylogeny
  • Streptococcal Infections* / genetics
  • Streptococcal Infections* / microbiology
  • Streptococcus agalactiae* / genetics
  • Streptococcus agalactiae* / pathogenicity

Grants and funding

RNZ and MF received funding from a Technology Strategy Board, Agri-Tech Catalyst - Early Stage Feasibility grant (Ref 132168), for funding the mutagenesis and in vivo studies. SDB received funding from the Bill & Melinda Gates Foundation (Opportunity INV-010426) for the JUNO Project, which funded sequencing of part of the isolates included in this study. DJ and in part CC salaries were provided by the JUNO project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.